Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

China flag China · Delayed Price · Currency is CNY
10.77
-0.06 (-0.55%)
Jul 28, 2025, 2:45 PM CST
-0.55%
Market Cap3.29B
Revenue (ttm)1.07B
Net Income (ttm)27.84M
Shares Out303.35M
EPS (ttm)0.09
PE Ratio117.92
Forward PEn/a
Dividend0.04 (0.37%)
Ex-Dividend DateMay 28, 2025
Volume13,750,059
Average Volume16,672,408
Open10.73
Previous Close10.83
Day's Range10.69 - 10.90
52-Week Range6.85 - 11.48
Beta0.50
RSI67.83
Earnings DateAug 23, 2025

About SHE:300534

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells Chinese patent medicines, health food, and APIs in China and internationally. The company offers Xuanfei Zhicough mixture, Yuanhu Zhitong dropping pills, Qiwei Wenyang capsules, Maxing cough capsule, and Astragalus Angelica capsules. Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD was founded in 2002 and is based in Lanzhou, China. [Read more]

Sector Healthcare
Founded 2002
Employees 634
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300534
Full Company Profile

Financial Performance

In 2024, SHE:300534's revenue was 1.04 billion, a decrease of -3.79% compared to the previous year's 1.08 billion. Earnings were 25.80 million, a decrease of -58.14%.

Financial Statements

News

There is no news available yet.